The "Fast Money" traders discuss the trade on this week's Dow winners, including Cisco, Pfizer, Boeing, JPMorgan and P&G.
Rep. Kevin Brady says he's "confident" that the border adjustment tax will be included in tax reform, despite opposition to the measure.
CNBC's Leslie Picker reports on David Tepper's Allergan bet as he ups the stake by 250%. With CNBC's Meg Tirrell.
The only way the U.S. can get its tax code into the 21st century is to move to a full consumption-based system, Rep. Devin Nunes says.
By 2030, 70 percent of HIV patients will be over 50. Now success of HIV drugs poses a new challenge: treating it as a geriatric condition.
Since May, Apple has rallied nearly 50 percent and gained more than $200 billion in market cap. But that's only part of the story.
For those who like investing with cupid in mind, one investment adviser shared his top three stock picks on Valentine's Day.
Charles Sizemore, CIO at Sizemore Capital Management, explains why he favors LVMH, L Brands and Pfizer stocks this Valentine's Day.
Allergan said it would buy Zeltiq Aesthetics for about $2.48 billion to gain access to its flagship body contouring technology.
Jim Cramer rattles off his take on caller favorite stocks, including the why it might be time to sell Panera.
The Republicans' border adjustment tax is really a hidden consumer tax, an "Americans for Affordable Products" advisor says.
A key segment of corporate America is lining up behind Trump's and the GOP's protectionist policies, and that's a mistake, says Jake Novak.
U.S. companies including major exporters GE and Boeing launched a coalition to back a House Republican plan to tax all imports.
British consumer goods maker Reckitt Benckiser is in advanced talks to buy baby formula maker Mead Johnson Nutrition for $16.7 billion.
The "Fast Money" traders share their first moves for the market open.
The Fed is not expected to take any action, but it could surprise markets and change sentiment Wednesday.
The "Fast Money" traders share their final trades of the day including FedEx Corp., Freeport-McMoRan and more.
U.S. equities traded mixed as investors continued to evaluate the latest policies from the White House.
Tony Coles, Yumanity Therapeutics CEO, former Onyx CEO, weighs in on President Trump's drug pricing rhetoric and meeting with pharma leaders. With CNBC's Meg Tirrell.
Some of the names on the move ahead of the open.